Literature DB >> 22956168

[Secondary vasculitides and vasculitis mimics].

K de Groot1, E Märker-Hermann.   

Abstract

Secondary vasculitis is a form of vasculitis for which an underlying disease is known. Diseases associated with secondary vasculitis include infections, drug hypersensitivity, malignancy, rheumatoid arthritis, collagen vascular disease and sarcoidosis. Moreover, there are numerous conditions that can mimic vasculitis clinically, in laboratory testing, radiographically and in histopathology. It is evident that distinguishing primary vasculitis from secondary vasculitis and also vascular inflammation from non-vasculitic disorders (vasculitis mimics) has significant therapeutic implications.

Entities:  

Mesh:

Year:  2012        PMID: 22956168     DOI: 10.1007/s00393-012-0986-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  17 in total

Review 1.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Infections that cause vasculitis.

Authors:  R Mader; E C Keystone
Journal:  Curr Opin Rheumatol       Date:  1992-02       Impact factor: 5.006

Review 3.  Cholesterol embolization syndrome.

Authors:  Itzhak Kronzon; Muhamed Saric
Journal:  Circulation       Date:  2010-08-10       Impact factor: 29.690

4.  Sino-nasal bony and cartilaginous destruction associated with cocaine abuse, S. aureus and antineutrophil cytoplasmic antibodies.

Authors:  S Simsek; X H de Vries; J A D Jol; A M E Spoelstra-de Man; P W B Nanayakkara; Y M Smulders; H F Mahieu; P M ter Wee
Journal:  Neth J Med       Date:  2006 Jul-Aug       Impact factor: 1.422

5.  A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine.

Authors:  Rachel L Gross; Jason Brucker; Asena Bahce-Altuntas; Maria A Abadi; Jules Lipoff; David Kotlyar; Peter Barland; Chaim Putterman
Journal:  Clin Rheumatol       Date:  2011-06-25       Impact factor: 2.980

6.  Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.

Authors:  Manuel Ramos-Casals; Norma Nardi; Mariana Lagrutta; Pilar Brito-Zerón; Albert Bové; German Delgado; Ricard Cervera; Miguel Ingelmo; Josep Font
Journal:  Medicine (Baltimore)       Date:  2006-03       Impact factor: 1.889

7.  Frequency of appearance of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) in Graves' disease patients treated with propylthiouracil and the relationship between MPO-ANCA and clinical manifestations.

Authors:  J Y Noh; T Asari; N Hamada; F Makino; N Ishikawa; Y Abe; K Ito; K Ito
Journal:  Clin Endocrinol (Oxf)       Date:  2001-05       Impact factor: 3.478

Review 8.  Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.

Authors:  Elena Csernok; Peter Lamprecht; Wolfgang L Gross
Journal:  Curr Opin Rheumatol       Date:  2010-01       Impact factor: 5.006

9.  Mesna side effects which imitate vasculitis.

Authors:  E Reinhold-Keller; J Mohr; E Christophers; K Nordmann; W L Gross
Journal:  Clin Investig       Date:  1992-08

Review 10.  Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective.

Authors:  N Nathani; M A Little; H Kunst; D Wilson; D R Thickett
Journal:  Thorax       Date:  2008-05-20       Impact factor: 9.139

View more
  2 in total

1.  [Polyarteritis nodosa: differential diagnostics and therapy].

Authors:  J H Schirmer; K Holl-Ulrich; F Moosig
Journal:  Z Rheumatol       Date:  2014-12       Impact factor: 1.372

2.  [Mimics in rheumatology : Possibilities for mistakes and differential diagnoses].

Authors:  I Kötter
Journal:  Z Rheumatol       Date:  2019-02       Impact factor: 1.372

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.